These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3521569)

  • 1. Treatment of acute rejection episodes in dog renal allograft recipients receiving cyclosporin A:ATG vs prednisolone.
    Kelly GE; Sheil AG
    Aust N Z J Surg; 1986 Mar; 56(3):251-5. PubMed ID: 3521569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithymocyte globulin for steroid resistant rejection in renal transplant recipients immunosuppressed with triple therapy.
    Richardson AJ; Higgins RM; Liddington M; Murie J; Ting A; Morris PJ
    Transpl Int; 1989 Apr; 2(1):27-32. PubMed ID: 2669801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.
    Sollinger H; Kaplan B; Pescovitz MD; Philosophe B; Roza A; Brayman K; Somberg K
    Transplantation; 2001 Dec; 72(12):1915-9. PubMed ID: 11773888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and economic analysis of short-course versus standard-course antithymocyte globulin (rabbit) induction therapy in deceased-donor renal transplant recipients.
    Marfo K; Akalin E; Wang C; Lu A
    Am J Health Syst Pharm; 2011 Dec; 68(23):2276-82. PubMed ID: 22095818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantation.
    Cantarovich D; Giral-Classe M; Hourmant M; Dantal J; Blancho G; Lerat L; Moreau A; Soulillou JP
    Nephrol Dial Transplant; 2000 Oct; 15(10):1673-6. PubMed ID: 11007839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selective use of antilymphocyte serum for cyclosporine treated patients with renal allograft dysfunction.
    Delmonico FL; Auchincloss H; Rubin RH; Russell PS; Tolkoff-Rubin N; Fang LT; Cosimi AB
    Ann Surg; 1987 Nov; 206(5):649-54. PubMed ID: 3314751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft.
    Grinyó JM; Gil-Vernet S; Seron D; Hueso M; Fulladosa X; Cruzado JM; Moreso F; Fernandez A; Torras J; Riera L; Castelao AM; Alsina J
    Nephrol Dial Transplant; 1998 Oct; 13(10):2601-4. PubMed ID: 9794567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Najarian JS; Fryd DS; Strand M; Canafax DM; Ascher NL; Payne WD; Simmons RL; Sutherland DE
    Ann Surg; 1985 Feb; 201(2):142-57. PubMed ID: 3882063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RS-61443 reverses acute allograft rejection in dogs.
    Platz KP; Bechstein WO; Eckhoff DE; Suzuki Y; Sollinger HW
    Surgery; 1991 Oct; 110(4):736-40; discussion 740-1. PubMed ID: 1925962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial monitoring of T-cell subset ratios with monoclonal antibodies in steroid- and antithymocyte globulin-treated patients with renal allotransplants.
    Lewis RE; Kirchner K; Preuss T; Raju S; Krueger R; Cuchens M; Bower JD; Cruse JM
    Clin Immunol Immunopathol; 1984 May; 31(2):241-53. PubMed ID: 6232027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of acute renal allograft rejection with adjunctive AG therapy.
    Filo RS; Smith EJ; Leapman SB
    Transplant Proc; 1981 Mar; 13(1 Pt 1):482-90. PubMed ID: 7022879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplantation GAD-autoantibody status to guide prophylactic antibody induction therapy in simultaneous pancreas and kidney transplantation.
    Ringers J; van der Torren CR; van de Linde P; van der Boog PJ; Mallat MJ; Bonifacio E; Roep BO; de Fijter JW
    Transplantation; 2013 Oct; 96(8):745-52. PubMed ID: 23912172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acute cellular rejection in renal transplantation patients on ciclosporin with antithymocyte globulin.
    Arndt R; Hammerer P; Huland E; Krämer-Hansen H; Huland H
    Urol Int; 1988; 43(3):139-44. PubMed ID: 3051619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
    Clark G; Walsh G; Deshpande P; Koffman G
    Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination treatment of low dose Anti-Thymocyte Globulin (ATG), Rituximab and high dose Sirolimus as induction agents in immune-conditioned recipients.
    Ravichandran P; Natrajan T; Jaganathan R
    Int Immunopharmacol; 2006 Dec; 6(13-14):1973-6. PubMed ID: 17161350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacoeconomic comparison of antithymocyte globulin and muromonab CD3 induction therapy in renal transplant recipients.
    Brennan DC; Schnitzler MA; Baty JD; Ceriotti CS; Lowell JA; Shenoy S; Howard TK; Woodward RS
    Pharmacoeconomics; 1997 Mar; 11(3):237-45. PubMed ID: 10165313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression.
    Laufer G; Miholic J; Laczkovics A; Wollenek G; Holzinger C; Hajek-Rosenmeier A; Wuzl G; Schreiner W; Buxbaum P; Wolner E
    J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1113-21. PubMed ID: 2586129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation.
    Colak T; Sevmiş S; Karakayali H; Moray G; Haberal M
    Transplant Proc; 2008; 40(1):123-5. PubMed ID: 18261564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.